Items 131 to 140 of 361 total

per page

Grid  List 

  1. THE CASE BOX
    Content Locked

    THE CASE BOX

    Osteology Foundation
  2. Vascularized Buccal Inversion Flap
    Content Locked
  3. Short and narrow implants, how far can we go?
    webinars

    Short and narrow implants, how far can we go?

    Christoph Hämmerle, José Nart
    In this webinar moderated by Prof Ronald Jung and Dr. Adrián Guerrero the expert presenters Prof. Christoph Hämmerle and Dr. José Nart discuss about the importance and benefits of using short and narrow implants.
  4. Osteology Research Scholars 2015
    Content Locked
  5. THE OSTEOLOGY CASE BOX
    Content Locked

    THE OSTEOLOGY CASE BOX

    The Osteology CASE BOX contains cases uploaded for different clinical scenarios. User decides whether they want to share their cases, or whether they only add the data for overall evaluation and compare it with the mean.
  6. ALVEOLAR RIDGE PRESERVATION IN DAMAGED SITE 4.7—AN EARLY STAGED OPEN-HEALING PROTOCOL IN HIGH-RISK PATIENTS TREATED WITH ORAL BISPHOSPHONATES
    Content Locked

    ALVEOLAR RIDGE PRESERVATION IN DAMAGED SITE 4.7—AN EARLY STAGED OPEN-HEALING PROTOCOL IN HIGH-RISK PATIENTS TREATED WITH ORAL BISPHOSPHONATES

    Objectives: The objective was to simplify the regenerative procedure using a minimally invasive technique. Ridge preservation at the time of the patient’s tooth avulsion was not possible because of acute infection. Surgery was performed using biomaterials during the early post-extractive healing process. The "early build-up technique", as used in healthy patients, was chosen to reduce comorbidity risks in a single high-risk patient.
    Methods: A 69-year-old woman had been treated with oral alendronate 70 mg weekly since 2001 because of a vertebral fracture caused by osteoporosis. She had experienced in anamnesis breast neoplasm in 2000 (and recurrence in 2015) and myocardial infarction for which she had a triple bypass in 2007 and angioplasty in 2014. The patient attended the clinic for chronic periodontitis and the tooth 4.7 was extracted because of recurrent periodontal abscesses. Before the extraction, cone beam computed tomography (CBCT) allowed evaluation of cortical wall thickness around the mobile mesial inclined 4.7 from the most significant eight cross sections (CS), and 16-mm mesiodistal bone assessment. The edentulous area 4.6 was partially included in the evaluation. Photographs were taken and periodontal probing performed 2 months after extraction of 4.7. The surgical protocol involved flapless avulsion of the tooth in October 2011 and the flap procedure 2 months later (December 2011). The early alveolar build-up was performed using bovine-derived xenograft and collagen matrix. The surgical design was restricted to keratinised gingiva 4.6–4.7. The intra-alveolar connective tissue of the thick vestibular flap was preserved and rotated on the second layer of the matrix to protect the wound. The exposed surface of the matrix resembled geometrically a post-extract alveolus and flap suture was performed without periosteal-releasing incisions to guide soft tissue proliferation (GGP; guided gingival proliferation).
    Results: No complications were reported after surgery. The exposed matrix surface was part of the GGP procedure. As in healthy patients, the exposed biomaterial surface was sealed after 4 weeks. The gain in keratinised gingiva was 2mm. The hard tissue outcome was detected by 16-mm mesiodistal CBCT changes before the extraction and after surgery. Before the extraction, the bone crest width in the distal area 4.7 was 6 mm in two cross-sections and 8–9 mm in three mesial cross sections (area missing 4.6). Near the roots in 4.7 in three central cross-sections, there was only 1 mm of lingual cortical wall with fenestration defects (1 CS) and vestibular bone was largely absent (>50%). The alveolar cavity was partially retentive. After lateral ridge regeneration the bone crest width was 10–12 mm in seven cross-sections, with the greatest linear horizontal bone gain (of 10 mm) in four central cross-sections. The lingual osseous fenestration was healed. Overall the lingual bone plate height in distal area 4.7 was decreased by 1–2 mm (three distal cross-sections), with no differences in central and mesial areas (five sections). The vestibular cortical wall height was 2–5 mm greater in the central and distal area 4.7 (six cross-sections), with no differences in the mesial area (two cross-sections). The vertical distance between bone crest and alveolar nerve level was 8–9 mm in all cross sections, without residual defect area. After 4 years of follow-up the 4.7 site is in a stable condition according to ortopantomography and photographs.
    Conclusions: In healthy patients, this surgical augmentation of horizontal alveolar bone and keratinised gingiva is problem-free, and was shown to be the case also in this high-risk patient, in whom implant surgery is contraindicated because of comorbid conditions and uncontrolled periodontitis. In healthy patients, implant insertion is possible 6–12 months after bone augmentation. The choice of the GGP protocol for this alendronate-treated patient was associated with fewer risks than surgery with primary intention healing of the wound. Further clinical trials should be conducted on the GGP protocol, and may show that covering bone substitutes with collagen matrix exposed during the early post-extractive wound healing process is a surgical step instead of a complication of the GBR procedure.
  7. REAL-TIME NAVIGATION: THE BEGINNING OF A NEW ERA IN GUIDED IMPLANT SURGERY
    poster

    REAL-TIME NAVIGATION: THE BEGINNING OF A NEW ERA IN GUIDED IMPLANT SURGERY

    Objectives: To demonstrate that dynamic guided surgery is as predictable as conventional surgery.
    Methods: Partially edentulous patients requiring a fixed rehabilitation were selected for this pilot study. No specific contraindications were established, and smokers were not excluded. An impression was taken pre-operatively using an irreversible hydrocolloid (Cavex CA37®) to fabricate a diagnostic cast for moulding the surgical stent (NaviStent®). Afterwards, a standard cone-beam CT (CBCT) scan was made with the NaviStent® in place using a Planmeca Promax 3-D Max®. Images were converted into DICOM files and transformed into a 3-D virtual model using the Navident® software. The potential implant locations were planned in a prosthesis-driven way. For preparing the osteotomy, the drilling axis of the handpiece and the twist drills were calibrated. The osteotomies were prepared at low speed using a high level of cooling. The navigation software guided the drilling procedure in real time. Before installing implants, an extra calibration procedure was performed for tracking the implant. The aim of this pilot study was to determine the clinical outcome up to 12 months post-operatively for implants installed using the Navident® guided surgery system.
    Results: Partially edentulous men (n = 6) and women (n = 7) were included in this pilot study (mean age 52.15 years; range 20–75). Out of these 13 patients, two were current smokers of more than 10 cigarettes per day. Twenty implants were inserted. No mechanical or biological complications occurred during the surgical procedure, and no major complaints were reported, such as hemorrhage, sinus pathology or severe post-operative pain. No implants were lost up to 1 year after insertion, resulting in 100% implant survival.
    Conclusions: Based on the results of this pilot study, real-time navigation is a promising technique. However, there is not yet enough evidence to show that the method is as safe and predictable as conventional implant surgery.
  8. HYBRID SCAFFOLDS COMPOSED OF BETA-TRICALCIUM PHOSPHATE (TCP), poly (D,L- lactic acid) (PDLLA) AND COLLAGEN FOR ALVEOLAR BONE AUGMENTATION
    Content Locked

    HYBRID SCAFFOLDS COMPOSED OF BETA-TRICALCIUM PHOSPHATE (TCP), poly (D,L- lactic acid) (PDLLA) AND COLLAGEN FOR ALVEOLAR BONE AUGMENTATION

    Objectives: Dimensional changes occur in the alveolar ridge after tooth loss, due to bone resorption. Bioactive ceramic scaffolds are available for bone alveolar augmentation, but their mechanical properties are still an issue during implantation. The aim of this study was to characterize the mechanical properties of synthesized β-TCP hybrid scaffolds coated with bioabsorbable collagen or PDLLA.
    Methods: β-TCP powder was obtained by reactive milling. Scaffolds were produced by the replica method from polyurethane foam patterns. Type I collagen or poly (D,L- lactic acid) (PDLLA) were used to coat the scaffolds by dip coating. The hybrid scaffolds were then divided into four groups: non-coated (GA); double immersion in collagen type I (GB); double immersion in PDLLA (GC); and ten immersions in PDLLA (GD). Samples were characterized by compressive tests, x-ray diffraction and scanning electron microscopy with energy dispersive x-ray analysis (SEM/EDS). Statistical analysis was performed by two-way ANOVA(p
    Results: Chemical and microscopic analyses revealed proper morphology of powder particles and scaffolds with or without polymeric coatings. Hybrid scaffolds of PDLLA had higher compressive strength (0.11 MPa ± 0.054) (p
    Conclusion: β-TCP scaffolds synthesised by the replica method showed proper morphology and size of interconnected pores. The PDLLA scaffold-coating method increased mechanical strength of the porous ceramic material, showing desirable properties such as high compressive strength, biocompatibility and osteoconductivity. These properties are essential in alveolar preservation procedures for resisting compression from soft tissues and occlusal stress from mastication.
  9. STEM CELL BONE ALLOGRAFTS IN MAXILLARY SINUS AND RIDGE AUGMENTATION – REPORT OF A CASE
    Content Locked

    STEM CELL BONE ALLOGRAFTS IN MAXILLARY SINUS AND RIDGE AUGMENTATION – REPORT OF A CASE

    Objectives: To evaluate the use of an allograft cellular matrix containing live stem cells for maxillary sinus and ridge augmentations.
    Methods: Maxillary sinus and ridge augmentations were performed using an allograft cellular matrix containing live stem cells. The post-operative results were evaluated by CT scans and peri-apical radiographs. Sinus augmentation was evaluated after 10 weeks. Radiographic bone tomography was similar to that of the native bone and the ridge augmentation resulted in a vertical ridge augmentation of 3–4mm. The cellular matrix was supplied by Brockton, MA and processed by AlloSource, Centennial, CO.
    Results: Following healing and approximately 10 weeks following surgery, an additional CT scan was taken. This showed that the native and augmented bone was of an adequate width for supporting an implant. Radiography revealed that the augmented bone had a similar texture to native bone, indicating formation of mature bone. The scan also revealed downward growth of the bone in a vertical direction, overlapping the crest of the native pre-maxillary bone. This was not attempted during the surgical procedure, and was a particular cause for concern.
    Conclusions: This use of allograft mesenchymal stem cells has been shown to be a reliable method for ridge augmentation, especially in the vertical direction in areas of severe ridge atrophy. Further studies are needed to support this finding in a more guided manner, especially for vertical ridge augmentation.
  10. DENTAL IMPLANT SURVIVAL IN HYPODONTIA PATIENTS: A RETROSPECTIVE STUDY
    Content Locked

    DENTAL IMPLANT SURVIVAL IN HYPODONTIA PATIENTS: A RETROSPECTIVE STUDY

    Objectives: Specialists in prosthodontics and restorative dentistry are often challenged by oral rehabilitation of patients with hypodontia. Implant rehabilitation is commonly used to replace developmentally missing teeth, but evidence of implant survival in hypodontia patients is scarce. The aim of this study was to present findings on short- to medium-term clinical outcomes, complications and survival rates of dental implants in patients with hypodontia who were treated in Birmingham, UK.
    Methods: A retrospective analysis was conducted of the clinical records of patients treated within the Oral and Maxillofacial Surgery Department at Queen Elizabeth Hospital and the Restorative Dentistry Department at the University of Birmingham Dental Hospital. All patients were identified from the hypodontia clinic database. Clinical variables were recorded, collated and compared with reports of adverse events during a follow-up period of up to 6.7 years. Patient data were collected using a pro forma regarding the number and the location of implants, the surgical procedure, and any surgical or restorative complications. All patients on the study had a review appointment within the previous 3 months. The data were analysed to determine the number of patients treated, the type and number of implants placed, the site of placement and type of augmentation used, and to identify any peri-operative and post-operative complications. The minimum, maximum and mean follow-up period was calculated and the number of implants per follow-up year were recorded.
    Results: There were 67 patients aged between 20 and 57 (average 28 years) who received 304 implants to replace anterior (54.9%) and posterior (45.1%) missing tooth units; 49% of implants were placed in the maxilla and 51% in the mandible; 36.5% were placed in non-grafted sites and 63.5% in grafted sites. Mandibular ramus augmentation was used in 80.3% of cases, iliac crest augmentation in 11.9%, and bovine origin xenografts in 7.8%. Post-surgical complications were experienced by 19.4% of patients; four had fenestration or dehiscence type defects around the implant, the graft failed in two, and seven had transient anaesthesia or paraesthesia in the inferior dental nerve distribution area. There were complications in 3.2% implants after completion of the restorative treatment, 40% of which were soft tissue complications (e.g. gingival inflammation); 60% were prosthodontic complications (e.g. screw loosening or ceramic fracture). All were minor and were resolved in-office or by replacement of the prosthesis. One implant failed within the first year, producing a survival rate of 9% within the observation period of up to 6.7 years (range 0.1 to 6.7; mean 2.7 years). Reviews were carried out in 0–2 years for 39.4% of implants, in 3–5 years for 57.6%, and in 6–7 years for 3%.
    Conclusions: The implant survival rate was 99.6% up to 6.7 years after surgery. This is higher than the implant survival rate reported in the another published study of implants in hypodontia patients, and higher than those reported in non-hypodontia patient studies. A post-implant complication rate of 19.4% in this study is similar to that of other studies, and similar restorative complications have been found in other studies in non-hypodontia patients. Implant rehabilitation is a successful option for replacing developmentally missing teeth, but short implants should be considered in cases requiring vertical ridge augmentation, because our failure and complication rates were higher in these cases.